Xanthohumol microbiome and signature in adults with Crohn’s disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial

Autor: Blake O. Langley, Jennifer Joan Ryan, John Phipps, Lita Buttolph, Brenna Bray, Joseph E. Aslan, Thomas O. Metz, Jan F. Stevens, Ryan Bradley

Publikováno v: Trials, Vol 23, Iss 1, Pp 1-14 (2022)

Abstract Background Xanthohumol (XN), a bioactive flavonoid from Humulus lupulus with anti-inflammatory properties, has potential benefits for patients with Crohn’s disease (CD), a type of inflammatory bowel disease. We recently completed and publi

Externí odkaz: https://doaj.org/article/039a4f7b59584d1eb7df35da4d543cfc

Mental health aspects of binge eating disorder: A cross-sectional mixed-methods study of binge eating disorder experts' perspectives

Autor: Brenna Bray, Chris Bray, Ryan Bradley, Heather Zwickey

Publikováno v: Frontiers in Psychiatry, Vol 13 (2022)

Binge eating disorder has high comorbidity with a variety of mental health diagnoses and significantly impairs quality of life. This mixed-methods cross-sectional survey study aimed to collect information from experts in the field about mental health

Externí odkaz: https://doaj.org/article/32ced0900aff426eabcb0a64ed9a0860

Overeaters Anonymous: An Overlooked Intervention for Binge Eating Disorder

Autor: David A. Wiss, Christine E Bray, Heather Zwickey, Brenna Bray, Boris C Rodríguez-Martín

Publikováno v: International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 18, Iss 7303, p 7303 (2021)

Binge eating disorder affects >2.8 million American adults and is characterized by low remission rates (52–62%) and 20–60% relapse rates. Fifty-six percent of individuals with binge eating disorder never receive treatment due to stigma, misconcep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba415dd8770c72d500125c631996796
http://europepmc.org/articles/PMC8305393

Corticosterone in the ventral hippocampus differentially alters accumbal dopamine output in drug-naïve and amphetamine-withdrawn rats

Autor: Matthew A. Weber, Gina L. Forster, Dana Bachmeier, Kaci A. Clement, Brenna Bray

Publikováno v: Neuropharmacology

Dysregulation in glucocorticoid stress and accumbal dopamine reward systems can alter reward salience to increase motivational drive in control conditions while contributing to relapse during drug withdrawal. Amphetamine withdrawal is associated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518b0861767602618df0b9b3d99cce9c
https://doi.org/10.1016/j.neuropharm.2019.107924